Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse

Academic Article


  • Importance: More than 225 000 surgeries are performed annually in the United States for pelvic organ prolapse (POP). Abdominal sacrocolpopexy is considered the most durable POP surgery, but little is known about safety and long-term effectiveness. Objectives: To describe anatomic and symptomatic outcomes up to 7 years after abdominal sacrocolpopexy, and to determine whether these are affected by concomitant anti-incontinence surgery (Burch urethropexy). Design, Setting, and Participants: Long-term follow-up of the randomized, masked 2-year Colpopexy and Urinary Reduction Efforts (CARE) trial of women with stress continence who underwent abdominal sacrocolpopexy between 2002 and 2005 for symptomatic POP and also received either concomitant Burch urethropexy or no urethropexy. Ninety-two percent (215/233) of eligible 2-year CARE trial completers were enrolled in the extended CARE study; and 181 (84%) and 126 (59%) completed 5 and 7 years of follow-up, respectively. The median follow-up was 7 years. Main Outcomes and Measures: Symptomatic POP failure requiring retreatment or self-reported bulge; or anatomic POP failure requiring retreatment or Pelvic Organ Prolapse Quantification evaluation demonstrating descent of the vaginal apex below the upper third of the vagina, or anterior or posterior vaginal wall prolapse beyond the hymen. Stress urinary incontinence (SUI) with more than 1 symptom or interval treatment; or overall UI score of 3 or greater on the Incontinence Severity Index. Results: Of 215 women enrolled in the extended CARE study, 104 had undergone abdominal sacrocolpopexy plus Burch urethropexy and 111 had undergone abdominal sacrocolpopexy alone. Pelvic organ prolapse and urinary incontinence failure rates gradually increased during 7 years of follow-up. ©2013 American Medical Association. All rights reserved.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Nygaard I; Brubaker L; Zyczynski HM; Cundiff G; Richter H; Gantz M; Fine P; Menefee S; Ridgeway B; Visco A
  • Start Page

  • 2016
  • End Page

  • 2024
  • Volume

  • 309
  • Issue

  • 19